Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Preconditioning Vaccine Sites for mRNA-Transfected Dendritic Cell Therapy and Antitumor Efficacy.

Methods in molecular biology (Clifton, N.J.) - 1 Jan 2016

Batich Kristen A, Swartz Adam M, Sampson John H

Abstract excerpt

Messenger RNA (mRNA)-transfected dendritic cell (DC) vaccines have been shown to be a powerful modality for eliciting antitumor immune responses in mice and humans; however, their application has not been fully optimized since many of the factors that contribute to their efficacy remain poorly understood. Work stemming from our laboratory has recently demonstrated that preconditioning the vaccine site with a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow Cells
Share to Cancer Vaccines
Share to Dendritic Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Electrophoresis

Share to Flow Cytometry

Share to Immunotherapy

Share to Transfection

Share to Vaccination

Source

Open in PubMed Open full text

Identifiers

PMID: 27076169
DOI: 10.1007/978-1-4939-3387-7_47
PMCID: PMC5527123

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Preconditioning Vaccine Sites for mRNA-Transfected Dendritic Cell Therapy and Antitumor Efficacy.PMID 27076169Read ↗

mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trendsSemantic proximity Read ↗

mRNA vaccine development and applications: A special focus on tumors (Review)Semantic proximity Read ↗

mRNA vaccines as cancer therapiesSemantic proximity Read ↗

Cancer immunotherapy with mRNA‐transfected dendritic cellsSemantic proximity Read ↗

Targeting human dendritic cells in situ to improve vaccines.Semantic proximity Read ↗

mRNA in cancer immunotherapy: beyond a source of antigenSemantic proximity Read ↗

Preconditioning Matters: Enhancing or Impairing Antitumor Immunity with DC VaccinesSemantic proximity Read ↗

Recruiting In Vitro Transcribed mRNA against Cancer Immunotherapy: A Contemporary Appraisal of the Current LandscapeSemantic proximity Read ↗

Cd73-LNPs promotes antitumor T-cell immunity via amplifying Tlr3-mediated immunostimulatory dendritic cell activationSemantic proximity Read ↗

Gene-modified dendritic cell vaccines for cancer.Semantic proximity Read ↗

Active immunization against cancer with dendritic cells: the near future.Semantic proximity Read ↗

Second generation of LNP based mRNA vaccine leads to a T cell–inflamed tumor microenvironment favorable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a cold tumor modelSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.